Valuation (69%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 25.30 | N/A |
| PEG Ratio (TTM) | -0.45 | N/A |
| P/S Ratio (TTM) | 0.51 | N/A |
| P/B Ratio (TTM) | 0.85 | N/A |
| P/FCF Ratio (TTM) | 16.63 | N/A |
| Price to 5YR AVG Earnings Ratio | 35.17 | N/A |
| Price to 5YR AVG FCF Ratio | 8.07 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.12% | N/A |
| ROE (TTM) | 3.29% | N/A |
| Net Profit Margin (TTM) | 2.05% | N/A |
| ROIC 5YR AVG | 11.75% | N/A |
Growth (85%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 33.55% | 55.90% | 23.41% |
| Revenue | 9.61% | -0.60% | 0.54% |
| Net Income | 33.78% | 57.66% | 23.53% |
| Cash Flow | 63.01% | 146.76% | 80.35% |
Health (81%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.64 | N/A |
| Quick Ratio (TTM) | 1.68 | N/A |
| D/E Ratio (TTM) | 0.02 | N/A |
| Interest Coverage (TTM) | 13.64 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 3.01 | N/A |
| LTL to 5YR AVG FCF | 0.06 | N/A |
| Shares Outstanding Growth 5YR AVG | 1.80% | N/A |